Earnings Call · Q3 FY2022·2022-11-13

Q3 22EPS -21.43%·Rev n/aQ2 22EPS +15.79%·Rev n/aQ1 22EPS -13.33%·Rev n/aQ4 21EPS +45.45%·Rev n/a⚠ consensus missing

Apyx Medical Corp APYX

Charles Goodwin — Chief Executive Officer

Tara Semb — Chief Financial Officer

−60.5%1d on move date−65.9% vs SPY3d−59.3%5d−65.7%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more APYX calls or request research access.

More APYX calls Browse calls Request research access